1290
V. Siddaiah et al. / Bioorg. Med. Chem. Lett. 17 (2007) 1288–1290
Table 2. Antioxidant activity of homoisoflavonoids
7. Siddaiah, V.; Venkata Rao, C.; Venkateswarlu, S.; Krish-
naraju, A. V.; Subbaraju, G. V. Bioorg. Med. Chem. 2006,
14, 2545.
a
Compound
(IC50 (lM)
NBT superoxide
scavenging activity
DPPH free radical
scavenging activity
8. General procedure for the preparation of E-homoisofl-
avonoids: A mixture of chroman-4-one 8 (1.22 mmol),
substituted benzaldehyde (1.76 mmol), and piperidine (five
drops) was heated at 70–80 ꢁC for 2 h. The cooled reaction
mixture was diluted with water (50 mL), acidified with dil
HCl, and extracted with ethyl acetate (3· 50 mL). The
combined EtOAc layer was washed with water (30 mL),
brine (30 mL) and dried over sodium sulfate. The residue
obtained after evaporation of the solvent was chromato-
graphed over silica gel column using mixtures of petro-
leum ether and ethyl acetate as eluents to give
homoisoflavonoids.
Intricatinol (1)
2
30.1
>200
26.5
8.5
10.1
>200
8.3
4
5
BHA
Vitamin C
4.5
34
966
852
25.1
BHA, butylated hydroxyanisole.
The lower the IC50 values, the higher the antioxidant activity.
a This indicates the significant difference at the level of P < 0:05, n ¼ 3.
9. Physical and spectral characteristics of compounds, 7,8-
dihydroxy-3-[(4-methoxyphenyl)methylene]chroman-4-
one (1): Light brown powder, mp 192–194 ꢁC (lit.5 mp
196–198 ꢁC). IR (KBr): 3394, 1658, 1602, 1254, 1173,
1150, 1071, 1030, 963 cmꢀ1. For 1H NMR see, Table 1.
13C NMR (DMSO-d6): d 180.2, 160.3, 152.4, 150.4, 135.3,
132.7, 132.2, 129.2, 126.6, 118.4, 115.2, 114.3, 110.5, 67.6,
55.3. MS (ESI, negative ion mode): m/z 297 (M–H)ꢀ.
8-Hydroxy-7-methoxy-3-[(4-methoxyphenyl)methylene]-
chroman-4-one (2). Light yellow powder, mp 96–98 ꢁC
(lit.5 mp 157–159 ꢁC). IR (KBr): 3305, 2932, 1658, 1603,
1288, 1255, 1176, 1102, 1027, 933 cmꢀ1. For 1H NMR see
Table 1. 13C NMR (DMSO-d6): d 181.5, 161.8, 153.9,
150.3, 136.7, 134.4, 133.1, 130.9, 128.0, 119.2, 117.9, 115.2,
106.9, 68.9, 56.7, 55.9. MS (ESI, positive ion mode): m=z
335 (M+Na)+.
DPPH radical scavenging activity. DPPH (1,1-diphenyl-
2-picrylhydrazyl) radical scavenging activity of homoi-
soflavonoids was determined by the method described
by Lamaisen et al.16,17 based on the reduction of metha-
nolic solution of the colored DPPH radical. From the
IC50 values (Table 2), again 7,8-dihydroxy-3-[(3,4-
dihydroxyphenyl)methylene]-chroman-4-one (5, IC50:
4.5 lM) was found powerful scavenger of DPPH free
radicals.
In summary, we have accomplished the synthesis of
intricatinol (1) and the proposed structure for intricatin
(2), two plant antimutagenic homoisoflavonoids isolated
from Hoffmanosseggia intricata in three steps, with two
synthetic analogs. The structure of natural intricatin
has been revised into 8-methoxybonducellin, a homoi-
soflavonoid isolated earlier from Caesalpinia pulcherr-
ima and Caesalpinia sappan. These homoisoflavonoids
were evaluated for their antioxidative potential by two
commonly used methods, the superoxide (NBT) and
DPPH free radical scavenging methods. Homoisoflavo-
noid 5 was found to be a potent antioxidant.
7,8-Dihydroxy-3-[(4-hydroxyphenyl)methylene]-chroman-
4-one (4). Light brown powder, mp 246–248 ꢁC. IR (KBr):
1
3371, 1662, 1618, 1244, 1173, 1068, 996 cmꢀ1. H NMR
(DMSO-d6): d 10.08 (2H, s, 2· Ar-OH), 8.76 (1H, s, Ar-
OH), 7.60 (1H, s, H-9), 7.31 (2H, d, J = 8.3 Hz, H-20,60),07.26
(1H, d, J = 8.6 Hz, H-5), 6.87 (2H, d, J = 8.3 Hz, H-3 ,50),
6.56 (1H, d, J = 8.6 Hz, H-6), 5.35 (2H, s, H-2). 13C NMR
(DMSO-d6): d 180.2, 158.9, 152.2, 150.4, 135.6, 132.7, 132.4,
128.3, 125.1, 118.3, 115.7, 115.2, 110.4, 67.7. MS (ESI,
negative ion mode): m/z 283 (M–H)ꢀ. Anal. Calcd for
C16H12O5: C, 67.60; H, 4.26. Found: C, 67.55; H, 4.32.
7,8-Dihydroxy-3-[(3,4-dihydroxyphenyl)methylene]-chro-
man-4-one (5). Light yellow powder, mp 220 ꢁC (dec). IR
(KBr): 3458, 3402, 3200, 1653, 1600, 1272, 1194, 1075,
980 cmꢀ1. 1H NMR (DMSO-d6): d 9.31–9.81 (br m, 4 H, Ar-
OH), 7.52 (1H, s, 0H-9), 7.25 (1H, d, J = 8.8 Hz, H-5), 6.83–
6.85 (3H, m, H-2 ,60), 6.77 (1H, dd, J = 8.3, 1.5 Hz, H-50),
6.55 (1H, d, J = 8.8 Hz, H-6), 5.34 (1H, d, J = 1.0 Hz, H-2).
13C NMR (DMSO-d6): d 180.2, 152.2, 150.3, 147.4,145.4,
135.9, 132.7, 128.1, 125.5, 123.0, 118.3, 117.5, 115.9, 115.2,
110.4, 67.7. MS (ESI, negative ion mode): m=z 299 (M–H)ꢀ.
Anal. Calcd for C16H12O6: C, 64.00; H, 4.03. Found: C,
63.97; H, 4.06.
Acknowledgments
We sincerely thank Sri G. Ganga Raju, Chairman, and
Mr. G. Rama Raju, Director, of Laila Impex for
encouragement. We are also thankful to Prof. A.
Srikrishna, Indian Institute of Science, for helpful dis-
cussions and CSIR, New Delhi, for the award of SRF
to one of the authors (V.S.).
References and notes
10. Bohler, P.; Tamm, Ch. Tetrahedron Lett. 1967, 3479.
11. McPherson, D. D.; Cordell, G. A.; Soejarto, D. D.; Pezzuto,
J. M.; Fong, H. H. S. Phytochemistry 1983, 22, 2835.
12. Namikoshi, M.; Nakata, H.; Saitoh, T. Phytochemistry
1987, 26, 1831.
1. Lockhart, I. M. In The Chemistry of Heterocylic Com-
pounds: Chromenes, chromanones and chromones; Ellis, G.
P., Ed.; John Wiley & Sons: New York, 1977.
2. A1 Nakib, T.; Bezjak, V.; Meegan, M. J.; Chandy, R. Eur.
J. Med. Chem. 1990, 25, 455.
13. McCord, J. M.; Fridovich, I. J. Biol. Chem. 1969, 244,
6049.
14. Venkateswarlu, S.; Ramachandra, M. S.; Subbaraju, G. V.
Bioorg. Med. Chem. 2005, 13, 6374.
3. Kirkiacharian, S.; Gomis, M.; Koutsourakis, P. Eur.
J. Med. Chem. 1989, 24, 309.
15. Wang, M.; Jin, Y.; Ho, C.-T. J. Agric. Food Chem. 1999,
47, 3974.
16. Lamaison, J. L.; Petitjean-Freyter, C.; Carnat, A. Pharm.
Acta Helv. 1997, 66, 185.
4. Desideri, N.; Olivieri, S.; Stein, M. L.; Sgro, R.; Orsi, N.;
Conti, C. Antiviral Chem. Chemother. 1997, 8, 545.
5. Wall, M. E.; Wani, M. C.; Manikumar, H. T.; Taylor, H.;
McGivney, R. J. Nat. Prod. 1989, 52, 774.
17. Matsuda, H.; Wang, T.; Managi, H.; Yoshikawa, M.
Bioorg. Med. Chem. 2003, 11, 5317.
6. Siddaiah, V.; Venkata Rao, C.; Venkateswarlu, S.; Sub-
baraju, G. V. Tetrahedron 2006, 62, 841.